Browse Category

NASDAQ:CPRX News 30 December 2025

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

Catalyst Pharmaceuticals stock drops 3% today as CPRX lags biotech in thin year-end trade

NEW YORK, December 30, 2025, 2:30 PM ET — Regular session Shares of Catalyst Pharmaceuticals, Inc. fell 3.0% to $23.33 in afternoon trading on Tuesday. The stock has traded between $23.30 and $24.10 so far in the session. The drop matters because trading can get choppy in the final days of the year, when fewer investors are active and price…

Stock Market Today

  • 3 ASX Penny Stocks Under A$700M Market Cap Worth Watching
    January 29, 2026, 10:48 PM EST. As the Australian market shows cautious recovery, investors eye ASX penny stocks with market caps under A$700 million for potential gains. These smaller companies like Beacon Minerals (A$477.57M) and Bubs Australia (A$125.18M) stand out for their financial resilience and growth outlook. Beacon Minerals, active in Western Australia's mineral development, posts revenue of A$92.73 million and maintains more cash than debt, signaling prudence despite a negative return on equity. Bubs Australia, specializing in goat dairy products across multiple countries, generates over A$100 million in revenue. Such stocks remain attractive as the Reserve Bank of Australia meets and global economic factors stir cautious optimism.
Go toTop